Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.
Published: June 2, 2021 at 10:52PM
from NYT Health https://ift.tt/2TBlNDM
Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.
Published: June 2, 2021 at 10:52PM
from NYT Health https://ift.tt/2TBlNDM
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)